Intravitreal aflibercept for diabetic macular oedema in real-world: 36-month visual acuity and anatomical outcomes
Marko Lukić(Moorfields Eye Hospital NHS Foundation Trust), Ranjan Rajendram(University College London), Zaid Shalchi(Moorfields Eye Hospital NHS Foundation Trust), Praveen J. Patel(UK Biobank), Gwyn Samuel Williams(Moorfields Eye Hospital NHS Foundation Trust), Philip Hykin(Moorfields Eye Hospital), Robin Hamilton(Moorfields Eye Hospital NHS Foundation Trust)
Cited by 29
Related Papers
A Prospective Randomized Trial of Intravitreal Bevacizumab or Laser Therapy in the Management of Diabetic Macular Edema (BOLT Study)
|Ophthalmology|2010|510
Single-Chain Antibody Fragment VEGF Inhibitor RTH258 for Neovascular Age-Related Macular Degeneration
|Ophthalmology|2016|183
Patterns of Peripheral Retinal and Central Macula Ischemia in Diabetic Retinopathy as Evaluated by Ultra-widefield Fluorescein Angiography
|American Journal of Ophthalmology|2014|142